Loading market data...
Latest Top News
Investor Confidence Grows as Strides Pharma Delivers Strong December Quarter
Strides Pharma Science Ltd reported consolidated revenue of ₹11.95 billion and net profit of ₹2.02 billion for the December quarter. The robust results highlight strong demand in generics and specialty pharmaceuticals, reinforcing Strides’ position as a key player in India’s pharmaceutical growth story.
Stay Ahead – Explore Now! Aarti Surfactants Penalized for Environmental Non-Compliance






